Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Glucobay | Bayer Schering Pharma | Bayer East Africa Ltd. | 50mg | 90 | Tablet | per tablet | KES 2,031.93 |
| Glucobay | Bayer Schering Pharma | Bayer East Africa Ltd. | 100mg | 90 | Tablet | per tablet | KES 2,924.31 |
| test4 | Aci Limited | C.Mehta & Co Ltd. | 0.02% | 52gm | Diagnostic | KES 330 |
| Acarbose More info | |
|---|---|
| Mode Of Action | It inhibits intestinal alpha-glucosidases hence delaying the digestion and absorption of starch and sucrose. |
| Drug Indication | Diabetes mellitus inadequately controlled by diet or by diet with oral hypoglycaemic agents. |
| Precautions | Monitor serum hepatic transaminase in patients on 200mg/day for the first six months; may enhance hypoglycaemic effect of insulin and sulphonylureas. Due to its MOA, hypoglycaemic episodes should be treated with oral glucose not sucrose. |
| Contra-Indications | Under 18 years; pregnancy; states that deteriorate due to increased gas formation (e.g. intestinal ulcer and hernia); breastfeeding; severe renal and hepatic impairment; inflammatory bowel disease; intestinal obstruction; colon ulceration; and history of abdominal surgery. |
| Side Effects | Flatulence and bowel sounds; diarrhoea; abdominal distension; abdominal pain (less common); hypersensitivity reactions; jaundice; and hepatitis. |
| Dosage | Initially 25mg TID at the start of each main meal. Dosage may be adjusted at 4-8 weeks intervals, first to 50mg TID then, if required, to 100mg TID. |
| Special Information | It is an oligosaccharide obtained from fermentation processes of the microorganism Actinoplanes utahensis |
| Pregnancy Category | Category B3 |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals show evidence of an increased occurrence of foetal damage, the significance of which is uncertain in human |
| Drug Category | DRUGS AFFECTING NUTRITION AND METABOLISM |
| Drug Sub-Category | Other medicines for treatment of diabetes |